Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT00501449 |
Other study ID # |
2006-0783 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
May 2007 |
Est. completion date |
September 22, 2020 |
Study information
Verified date |
November 2020 |
Source |
M.D. Anderson Cancer Center |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The specific aims of the study include:
1. Profile the demographic, health-related, psychosocial and behavioral characteristics of
adults with MEN1 or MEN2.
2. Evaluate MEN-specific distress as well as adherence to surveillance regimens among
adults with MEN1 or MEN2, and identify associated with those outcomes.
Description:
The proposed cross-sectional study is intended to obtain information regarding current
surveillance behaviors and other psychosocial outcomes among persons affected by the multiple
endocrine neoplasia (MEN) 1 or MEN2, which are inherited conditions.
Study participants will include patients who have been seen previously at MDACC for
evaluation of MEN1 or MEN2. Because this is the first time investigators are contacting these
patients to invite them to participate in psychosocial research, the proposed study also will
help determine the feasibility of conducting similar studies in the future.
Investigators anticipate that data gathered from this study will enhance existing knowledge
about the psychological and behavioral aspects of the MEN syndromes, and will inform future
research efforts directed toward this understudied population.